Tenascin-C as a noninvasive biomarker of coronary artery disease.
Akram GholipourFarshad ShakerianAli ZahedmehrMaziar OveiseeMajid MalekiSeyed Javad MowalMahshid MalakootianPublished in: Molecular biology reports (2022)
Our study is the first to confirm that altered TNC expression is associated with pathological CAD conditions in Iranian patients. The expression of TNC is involved in endothelial differentiation and CAD development. Accordingly, TNC can serve as a valuable noninvasive biomarker with potential application in CAD diagnosis.
Keyphrases
- coronary artery disease
- poor prognosis
- end stage renal disease
- percutaneous coronary intervention
- cardiovascular events
- coronary artery bypass grafting
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- binding protein
- cardiovascular disease
- aortic stenosis
- heart failure
- left ventricular
- climate change